Galil Medical Announces New NICE Guidance for Laparoscopic Renal Cryoablation

NICE guidance for laparoscopic cryotherapy of renal cancer outlines an improved patient pathway for those seeking renal cryotherapy as a first line treatment. Galil Medical provided NICE with broad clinical evidence supporting the safety and efficacy of renal cryotherapy procedures.

Arden HIlls, MN (PRWEB) August 26, 2011

Galil Medical, a global leader in minimally invasive cryotherapy cancer treatments, announced today that NICE (National Institute for Health and Clinical Excellence) guidance has been secured for laparoscopic cryotherapy of renal cancer.

In the recently issued guidance, NICE states: “Current evidence on the efficacy and safety of laparoscopic cryotherapy for renal cancer is adequate to support the use of this procedure provided that normal arrangements are in place for clinical governance, consent and audit.”

Urologists and Galil Medical have been involved throughout the consultation process, to ensure that NICE had access to the most updated information during their review of this treatment. As part of the public commentary process, Galil Medical was able to provide NICE with broader clinical evidence supporting the safety and efficacy of renal cryotherapy procedures.

The new NICE guidance outlines an improved patient pathway for those seeking renal cryotherapy as a first line treatment. This provides patients with a true alternative to the more invasive surgical techniques that are currently offered.

“Galil Medical is the only company solely committed to advancing cryotherapy over a broad range of applications,” Marty Emerson (Galil’s CEO) commented. “We believe that the NICE Guidance will further solidify our position that cryotherapy is the treatment of choice for laparoscopic renal procedures and will position Galil Medical as the preeminent cryotherapy company in the world. Our goal is to provide cryotherapy specialists with a broad range of product choices, allowing these physicians the flexibility to treat a wider range of patients.”

The NICE guidance may be viewed at http://guidance.nice.org.uk/IPG405/Guidance/pdf/English

About Galil Medical- Galil Medical is a global leader in delivering innovative cryotherapy solutions. The company is addressing patient conditions across multiple physician specialties; treatment areas include conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. Company offices are located in Arden Hills, Minnesota; Yokneam, Israel; and London, United Kingdom. Shareholders include Thomas, McNerney & Partners, The Vertical Group, and Investor Growth Capital.

Contact information:

Derek Jerome

Clinical Affairs and Technical Services Director

Tel: +44 (0) 1293 459848

Email: derek.jerome(at)galilmedical(dot)com

Sally Rogers

Marketing Director, Europe

Tel: +44 (0) 1293 459848

Email: sally.rogers(at)galilmedical(dot)com

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/8/prweb8748024.htm